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Summary
Background In sub-Saharan Africa, little is known about the damage to respiratory health caused by biomass smoke 
and tobacco smoke. We assessed the prevalence of chronic obstructive pulmonary disease (COPD) and related risk 
factors in a rural region of Uganda.
Methods We did this prospective observational cross-sectional study in rural Masindi, Uganda. We randomly selected 
people above the age of 30 years from 30 villages. Trained local health-care workers asked validated questionnaires 
and administered spirometry to participants. We deﬁ ned COPD as FEV1:FVC less than the lower limit of normal. We 
calculated prevalence of COPD and tested its association with risk factors.
Findings Between April 13, and Aug 14, 2012, we invited 620 people to participate, of whom 588 provided acceptable 
spirometry and were analysed. Mean age was 45 years (SD 13·7); 297 (51%) were women. 546 (93%) were exposed to 
biomass smoke. The prevalence of COPD was 16·2% (15·4% in men, 16·8% in women). Prevalence was highest in 
people aged 30–39 years (17 [38%] of 45 men, 20 [40%] of 50 women). 20 (44%) of 45 men with COPD were current 
smokers (mean age 40 years, SD 7·5), 11 (24%) were former smokers (mean age 49 years, SD 11·0); four [8%] of 
50 women were current smokers (mean age 52 years, SD 18·1), nine (18%) were former smokers (mean age 64 years, 
SD 16·2). Mean Clinical COPD Questionnaire score was 0·81 (SD 0·78), mean Medical Research Council dyspnoea 
score was 1·33 (SD 0·65); 28 (30%) of 95 patients had had one or more exacerbations past 12 months. COPD was 
associated with wheeze (odds ratio 2·17, 95% CI 1·09–4·34; p=0·028) and being a former smoker (1·96, 1·07–3·59; 
p=0·029).
Interpretation In this rural district of Uganda, COPD starts early in life. Major risk factors were biomass smoke for 
both sexes and tobacco smoke for men. In addition to high smoking prevalence in men, biomass smoke could be a 
major health threat to men and women in rural areas of Uganda.
Funding International Primary Care Respiratory Group.
Copyright © van Gemert et al. Open Access article distributed under the terms of CC BY.
Introduction
Non-communicable diseases have often been considered 
less important than communicable diseases in low-
income and middle-income countries.1 However, chronic 
obstructive pulmonary disease (COPD), once regarded as 
a disease of high-income countries, is now recognised as 
common in low-income and middle-income countries.2,3 
COPD is the fourth leading cause of death worldwide, 
and is predicted to become the third by 2020, surpassing 
the combined mortality for malaria, tuberculosis, and 
HIV/AIDS in Africa.4–6
The main causes of COPD in high-income countries 
are tobacco smoke and occupational exposure, but in 
low-income and middle-income countries use of biomass 
fuel (wood, dung, crop residues, and charcoal) for 
cooking and domestic heating is also a major cause of 
COPD and childhood respiratory infections.2,7–9 Biomass 
fuels are often burned ineﬃ  ciently in open ﬁ res, leading 
to high levels of indoor air pollution, exceeding health 
limits speciﬁ ed by international standards of ambient air 
quality.7 Worldwide, biomass fuels are used in about 50% 
of households, exposing more than 3 billion people to 
their adverse eﬀ ects.9,10 Other contributing risk factors for 
COPD in low-income and middle-income countries are a 
history of tuberculosis, untreated asthma, respiratory 
infections, kerosene-based lighting, and socioeconomic 
factors such as malnutrition and poverty.5
In sub-Saharan Africa, particularly in rural regions, 
knowledge of COPD is very poor; many people (health-
care workers, government oﬃ  cials, and the public) are 
unaware of the damage to respiratory health caused by 
tobacco and biomass fuel smoke.11 Data for the burden of 
COPD and related risk factors are scarce or not available. 
Some surveys have been done in Africa;12 however, they 
have often been of poor quality—for example, COPD 
diagnosis based on the presence of symptoms rather than 
spirometry or bronchodilator use.10,12 Only two population 
studies have used appropriate methods and population-
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representative sampling. In 2007, the Burden of Lung 
Disease study13 in South Africa showed a high prevalence 
of stage 2 or higher COPD (22·2% in men and 16·7% in 
women) in an urban population older than age 40 years, 
associated with previous tuberculosis and occupational 
exposure in addition to smoking. In 2008–09, a survey 
done in urban and rural Rwanda reported a COPD 
prevalence of 9·6% in people older than age 45 years.14
We did a study (FRESH AIR Uganda) to assess the 
prevalence and burden of COPD and related risk factors 
in adults in a poor rural region of Uganda.
Methods
Study design and participants
We did this population-based, observational, cross-
sectional study between April 13, and Aug 14, 2012, in the 
rural district of Masindi (population 350 000) in Uganda, 
a low-income country with an average life expectancy of 
52 years (48 years for men, 57 years for women).15 25 local 
nurses and health oﬃ  cers were recruited as research 
assistants and received a 5-day training course in high-
quality spirometry.16
We chose Masindi district because it had a stable 
population in a deﬁ ned rural area and a functional health 
system. In collaboration with the National Bureau of 
Statistics in Uganda, we selected 30 villages with a 
probability proportional to their size. Each village contained 
an estimated 150 households; each household consisted of 
1·5 adults on average. Selected villages were visited to 
count the households. In each village, 20 households were 
then selected, with simple random sampling using R 
statistical software. From the chosen households all 
eligible men and women were invited to participate.
Exclusion criteria were age younger than 30 years, 
history of any mental illnesses; myocardial infarction in 
the past 6 weeks; hospital admission for cardiac illnesses 
within the past 6 months; thoracic, abdominal, or eye 
surgery (or retinal detachment) in the past 6 weeks; 
active tuberculosis; pregnancy; and present lung 
infection (participants were included after recovery). Age 
30 years was chosen as the cutoﬀ  to avoid missing people 
with premature airﬂ ow obstruction because exposure to 
biomass smoke starts during early childhood.6–11 
The liaison oﬃ  cer from the district health oﬃ  ce visited 
the villages and, together with the village leader, 
explained the purpose of the survey to eligible 
participants. Each participant signed an informed 
consent form, or in case of illiteracy, thumb-printed and 
signed by a witness. The study was approved by the 
Makerere University School of Medicine Research and 
Ethics Committee and the Uganda National Council for 
Science and Technology.
Procedures
Weight and height were measured. A screening 
questionnaire, developed from diﬀ erent validated 
questionnaires and adapted to local circumstances, was 
completed during a face-to-face interview (appendix).17–19 
The questions included tribal origin, education, 
occupation, living in tobacco-growing areas, respiratory 
symptoms (cough, sputum, wheezing, shortness of 
breath), Medical Research Council dyspnoea scale 
score, chest infections, tobacco use, biomass fuel use, 
cooking and sleeping areas, tuberculosis, comorbidities, 
drug treatments, admission to hospital, and visits to 
health centres.
All participants underwent spirometry after 
explanation by a research assistant in their local 
language. Spirometry was done in accordance with the 
American Thoracic Society and European Respiratory 
Society recom mendations: at least three acceptable and 
reproducible blows with the largest and second-largest 
values for both forced vital capacity (FVC) and forced 
expiratory volume in 1 s (FEV1) within 150 mL or no 
more than 5% diﬀ erence; the largest values for FVC and 
FEV1 were considered the best and used for analysis.6,16 
Spirometry was done while seated, using Pneumotrac 
with Spirotrac V software (version 1.06). A new ﬁ lter 
was applied for each measurement to avoid 
contamination. Spirometers were calibrated every 
morning with a 1 L syringe and weekly with a biological 
control.
In most epidemiological surveys, COPD is deﬁ ned by 
spirometry and few clinical characteristics.20 This contrasts 
with clinical guidance recommending a diagnosis based 
on compatible spirometry and clinician’s assessment of 
exposure to risk factors, symptoms, limitations, health-
related quality-of-life, and exacerbations.6,16
We used a pre-bronchodilator FEV1:FVC ratio of less 
than 0·8 or an FVC of less than 80% as cutoﬀ s for 
whether or not to do a post-bronchodilator assessment, 
to avoid underestimating FVC, which could result in a 
normal FEV1:FVC ratio.21 Participants took a short-acting 
bronchodilator (salbutamol 200 μg) administered with a 
Redihaler (to avoid possible infections with a spacer) and 
spirometry was repeated 15 min thereafter. All 
spirometry results were reviewed weekly by the 
investigators; those which did not meet the quality 
criteria were repeated.
The Global Initiative for Chronic Obstructive Lung 
Disease deﬁ nition of airﬂ ow obstruction includes a 
ﬁ xed FEV1:FVC ratio of less than 0·7 after administration 
of an inhaled bronchodilator.6 Because this deﬁ nition 
could lead to over-diagnosis in elderly participants and 
under-diagnosis in young participants, we used a lower 
limit of normal threshold to deﬁ ne COPD—ie, 
participants below the ﬁ fth percentile of the predicted 
FEV1:FVC ratio (calculated with GLI2012 
DataConversion software; version 3.3.1).22–24 
Classiﬁ cation of severity of COPD was based on the 
Global Initiative for Chronic Obstructive Lung Disease 
criteria: mild obstruction, FEV1 ≥80%; moderate 
obstruction, FEV1 50–79%; severe obstruction, FEV1 
30–49%; and very severe obstruction, FEV1 <30%.6,20
See Online for appendix
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We assessed health-related quality-of-life with the 
Clinical COPD Questionnaire, a ten-item questionnaire 
divided into three domains (symptoms, mental state, and 
functional state) and translated to the main local 
languages.25 The ﬁ nal mean score of the Questionnaire 
was calculated, with a higher score representing worse 
health status.6,20
Statistical analysis
The intended sample size was 600 participants, 
calculated to give an acceptable degree of reliability for 
estimating prevalence (for an estimate prevalence of 
15%, 95% CI 12·1–17·9).13 We compared COPD 
prevalence in men and women with a χ² test. We did 
univariate analyses to evaluate associations between 
COPD and possible risk factors, selected on basis of 
previously studies.2,3,6 For normally distributed variables 
we used Student’s t tests and Pearson correlation 
coeﬃ  cient, and for non-normally distributed variables 
we used Mann-Whitney U tests and Spearman’s 
correlation coeﬃ  cient. The risk factors were age, sex, 
occupation, wheeze, cough, shortness of breath, 
smoking status, pack years, time cooking indoors, time 
cooking outdoors, respiratory infections, asthma, heart 
failure, tuberculosis, and socioeconomic factors. We 
included risk factors that had a p value lower than 0·2 in 
the univariate analyses in subsequent multivariate 
regression analysis using the backward Wald method.26 
Selection of the logistic models was based on 
Nagelkerke’s R², Hosmer-Lemeshow test, and the 
receiver operating characteristic curve. We considered 
p values less than 0·05 as statistically signiﬁ cant and 
p values of 0·05–0·1 as trends. We did the statistical 
analysis with SPSS (version 20).
Role of the funding source
The funder of the survey had no role in study design, 
data collection, data analysis, data interpretation, or 
writing of the report. The corresponding author had full 
access to all the data and had ﬁ nal responsibility for the 
decision to submit for publication.
Results
Of the 620 people invited to participate, 609 underwent 
spirometry (ﬁ gure 1). 588 (97%) of 609 people (291 men 
and 297 women) provided acceptable spirometry (ﬁ gure 1). 
We detected no statistically signiﬁ cant diﬀ erences between 
the 588 people with acceptable spirometry and the 
21 people without acceptable spirometry in terms of age, 
sex, smoking behaviour, and tuberculosis infection (data 
not shown). Mean age was 45·2 years (SD 13·6); 414 (70%) 
participants were aged 30–49 years. 485 (83%) lived in 
rural areas and 440 (75%) were farmers. Electricity was not 
available for 545 (93%) participants; 552 (94%) used 
kerosene-based lighting.
Almost all participants, both men and women, were 
exposed to biomass smoke, indoor as well as outdoor 
(table 1). In 521 (98%) of 546 exposed participants, wood 
was the main solid fuel for cooking, used in an open ﬁ re. 
Smoking was more common in men than in women 
(table 1), particularly among young men: 52 (52%) of 
100 male smokers were younger than 39 years (data not 
shown).
According to the deﬁ nition of COPD as FEV1:FVC less 
than the lower limit of normal, the prevalence of COPD 
Figure 1: Study participants
620 people invited to participate
609 assessed
545 with acceptable spirometry 64 participants with unacceptable spirometry 
43 participants with acceptable spirometry
 when repeated
588 analysed
11 excluded
 4 withdrew consent
 2 too infirm
 5 not eligible
21 excluded
 5 refused repeat spirometry
 16 unacceptable spirometry
  when repeated
 Men (n=291) Women (n=297)
Age (years) 45·0 (12·8) 45·4 (14·5)
Body-mass index (kg/m²) 22·2 (3·2) 23·7 (4·9)
Education
None 25 (8·6%) 93 (31·3%)
Primary (age 7–13 years) 189 (64·9%) 169 (56·9%)
Secondary (age 13–19 years) 63 (21·6%) 28 (9·4%)
Tertiary (age >19 years) 14 (4·8%) 7 (2·4%)
Smoking status
Current smoker 100 (34·4%) 22 (7·4%)
Former smoker 63 (21·6%) 24 (8·1%)
Never smoker 128 (44·0%) 251 (84·5%)
Biomass fuel use
Indoor exposure 265 (91·1%) 281 (94·6%)
Hours exposed per day 3·1 (2·5) 5·2 (2·4)
Years exposed 25·5 (18·4) 33·3 (18·2)
Outdoor exposure 262 (90·0%) 282 (94·9%)
Hours exposed per day 1·3 (1·7) 1·9 (2·5)
Years exposed 20·3 (16·9) 25·5 (17·7)
Data are mean (SD) or number (%). 
Table 1: Demographic characteristics of study population
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was 16·2% (95 of 588 participants); 50 (52·6%) were 
women. The mean age of patients with COPD was 
46·7 years (SD 14·0). Among participants with COPD, 
17 (38%) of 45 men and 20 (40%) of 50 women were aged 
30–39 years; seven (7·4%) were older than 70 years 
(ﬁ gure 2). Most participants had mild airﬂ ow obstruction, 
a ﬁ fth had moderate obstruction, and few had severe 
obstruction; no participants had very severe obstruction 
(table 2). 12 (2%) of 588 participants had asthma and 
eight (1·4%) had a restrictive spirometry pattern. Almost 
all patients had never had tuberculosis; 5% did not know 
(table 3). 27 (4·6%) of 588 participants reported being 
HIV positive.
According to the Global Initiative for Chronic Obstructive 
Lung Disease criterion, COPD prevalence was 12·4% (73 
of 588 participants); 32 (43·8%) were women. Mean age of 
COPD patients using this criterion was 55·5 years 
(SD 14·7); 11 (15·1%) were aged 30–39 years and 15 (20·5%) 
were older than 70 years (appendix).
Mean Clinical COPD Questionnaire score was 0·81 
(SD 0·78); the mean score for the symptoms domain 
was 1·09 (SD 0·95), for the mental state domain it was 
0·60 (SD 1·03), and for the functional state domain it 
was 0·64 (SD 0·88; table 2). The mean Medical 
Research Council dyspnoea score was 1·33 (SD 0·66) 
for participants with COPD, and 1·31 (SD 0·59) for 
participants without COPD. One or more exacerbations 
within the previous 12 months were reported by 28 
(29·5%) of 95 participants with COPD, increasing with 
age (20% for people aged 30–39 years, 23% for people 
aged 40–49 years, 23% for people aged 50–59 years, 
67% for those aged 60–69 years, and 57% for people 
aged >70 years). About a ﬁ fth of participants with 
COPD had two or more exacerbations in the past 12 
months (table 3). The appendix shows the relation 
between airﬂ ow obstruction, cough, and dyspnoea 
score of 2 or more.
546 (92·9%) of 588 participants were exposed to 
indoor biomass smoke and 544 (92·5%) were exposed 
to outdoor biomass smoke. Univariate analysis showed 
that exposure did not diﬀ er signiﬁ cantly between 
COPD and non-COPD participants (table 3). The 
univariate analysis also showed that smoking status 
was associated with COPD (table 3). Cough and wheeze 
were signiﬁ cantly more common in patients with 
Figure 2: Age of participants with chronic obstructive pulmonary disease
Chronic obstructive pulmonary disease deﬁ ned as ratio of forced expiratory volume in 1 s to forced vital capacity 
less than the lower limit of normal.
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Age (years)
Men
Women
Men (n=45) Women (n=50)
Symptoms
Cough 15 (33·3%) 14 (28·0%)
Phlegm 13 (28·9%) 8 (16·0%)
Wheeze 9 (20·0%) 7 (14·0%)
Out of breath 4 (8·9%) 6 (12·0%)
MRC dyspnoea score 1·31 (0·70) 1·34 (0·63)
Clinical COPD Questionnaire score
Total 0·76 (0·67) 0·85 (0·87)
Symptom 1·13 (0·84) 1·05 (1·05)
Mental 0·61 (1·10) 0·59 (0·97)
Functional 0·47 (0·60) 0·79 (1·05)
Exacerbations in the past 12 months
0 32 (71·1%) 35 (70·0%)
1 2 (4·4%) 6 (12·0%)
2 4 (8·9%) 4 (8·0%)
3 or more 7 (15·6%) 5 (10·0%)
Spirometry*
FVC (L) 4·03 (0·79) 2·91 (0·72)
FVC (% predicted) 116·4 (21·1) 116·8 (21·1)
FEV₁ (L) 2·63 (0·59) 1·98 (0·64)
FEV₁ (% predicted) 91·7 (17·2) 91·8 (20·3)
FEV₁:FVC 0·64 (0·07) 0·66 (0·06)
Severity in GOLD classiﬁ cation
1 (mild) 37 (82·2%) 37 (74·0%)
2 (moderate) 7 (15·6%) 12 (24·0%)
3 (severe) 1 (2·2%) 1 (2·0%)
4 (very severe) 0 0
Data are n (%) or mean (SD). COPD=chronic obstructive pulmonary disease. 
GOLD=Global Initiative for Chronic Obstructive Lung Disease. MRC=Medical 
Research Council. FVC=forced vital capacity. FEV₁=forced expiratory volume in 1 s. 
*Post-bronchodilator.
Table 2: Clinical characteristics of participants with COPD (deﬁ ned as 
FEV₁:FVC less than the lower limit of normal)
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COPD than in participants without COPD (appendix). 
Heart failure was also signiﬁ cantly associated with 
COPD (table 3). We detected no signiﬁ cant diﬀ erences 
between participants with and without COPD with 
regards to age, sex, education, tribal origin, asthma, 
chest infections, living in a tobacco-growing area, type 
of cooking area, hospital admission in the past 2 years, 
and health centre visits in the past 2 years. Too few 
participants had HIV/AIDS or tuberculosis to assess 
associations for these diseases. We detected a 
correlation between age and years of exposure to 
biomass smoke (indoors r=0·564, p<0·0001 and 
outdoors r=0·603, p<0·0001), and age and dyspnoea 
score (r=0·291, p<0·0001).
Women were more exposed than were men to biomass 
smoke, both indoors and outdoors and both in terms of 
hours per day and number of years (all p<0·0001). 
Univariate analyses within sexes showed an association 
with COPD among men with more than two chest 
infections per year, and a trend among men in villages in 
tobacco-growing areas (table 3).
Among participants with COPD, 20 (44%) of 45 men 
and four (8%) of 50 women were current smokers; their 
mean age was 40·4 years for men and 52·0 years for 
women (65% of men compared with 5% of women aged 
30–39 years were current smokers). 11 (24%) men and 
nine (18%) women were former smokers; their mean 
age was 48·6 years and 63·8 years, respectively 
(ﬁ gure 3).
Logistic regression analyses showed an association of 
wheeze and being a former smoker with the presence of 
COPD; cough, current smoker, heart failure, and hours 
per day cooking indoors showed trends for association 
with COPD (table 4).
Non-COPD (n=493) COPD (n=95) p value (non-COPD vs COPD)
Men (n=246) Women (247) Men (n=45) Women (n=50) Men Women Both sexes
Smoking status 0·152 0·017 0·046
Current smoker 80 (32·5%) 18 (7·3%) 20 (44·4%) 4 (8·0%) 0·121 0·861 ··
Former smoker 52 (21·1%) 15 (6·1%) 11 (24·4%) 9 (18·0%) 0·621 0·005 ··
Never smoker 114 (46·3%) 214 (86·6%) 14 (31·1%) 37 (74·0%) 0·058 0·024 ··
Indoor biomass fuel
Participants exposed 225 (91·5%) 235 (95·1%) 40 (88·9%) 46 (92·0%) 0·578 0·370 0·335
Years exposed 26·1 (18·3) 32·9 (17·9) 22·0 (18·2) 36·2 (19·5) 0·168 0·241 0·965
Hours exposed per day 3·1 (2·6) 5·1 (2·6) 3·4 (2·1) 5·6 (2·6) 0·553 0·172 0·145
Outdoor biomass fuel
Participants exposed 221 (89·8%) 236 (95·5%) 41 (91·1%) 46 (92·0%) 0·793 0·296 0·704
Years exposed 20·3 (17·0) 24·7 (17·5) 20·4 (16·1) 26·7 (18·6) 0·989 0·464 0·502
Hours exposed per day 1·2 (1·7) 1·9 (2·5) 1·6 (1·7) 2·0 (2·5) 0·380 0·939 0·143
Cooking area 0·117 0·297 0·711
Same building 44 (17·9%) 26 (14·6%) 8 (17·8%) 10 (20·0%) ·· ·· ··
Separate building 202 (82·1%) 221 (85·4%) 37 (82·2%) 40 (80·0%) ·· ·· ··
Village in tobacco-growing area 106 (43·1%) 91 (36·8%) 26 (57·8%) 18 (36·0%) 0·069 0·910 0·249
Chest infections 0·007 0·541 0·266
None 30 (12·2%) 20 (8·1%) 4 (8·9%) 5 (10·0%) 0·526 NA ··
1 or 2 per year 134 (54·5%) 138 (55·9%) 15 (33·3%) 31 (62·0%) 0·090 0·425 ··
>2 per year 82 (33·3%) 89 (36·0%) 26 (57·8%) 14 (28·0%) 0·020 0·330 ··
Tuberculosis NA* NA* NA*
Ever had and treated 5 (2·0%) 4 (1·6%) 1 (2·2%) 2 (4·0%) ·· ·· ··
Never had 228 (92·7%) 238 (96·4%) 40 (88·9%) 43 (86·0%) ·· ·· ··
Does not know 13 (5·3%) 5 (2·0%) 4 (8·9%) 5 (10·0%) ·· ·· ··
Currently being treated 0 0 0 0 ·· ·· ··
Had heart failure? 0·042 0·113 0·013
No 242 (98·4%) 236 (95·5%) 42 (93·3%) 45 (90·0%) ·· ·· ··
Yes 4 (1·6%) 11 (4·5%) 3 (6·7%) 5 (10·0%) ·· ·· ··
Had HIV/AIDS? NA* NA* NA*
No 106 (43·1%) 126 (51·0%) 20 (44·4%) 24 (48·0%) ·· ·· ··
Yes 8 (3·3%) 14 (5·7%) 2 (4·4%) 3 (6·0%) ·· ·· ··
Did not know 132 (53·6%) 107 (43·3%) 23 (51·2%) 23 (46·0%) ·· ·· ··
Data are n (%) or mean (SD). *Too few participants to calculate p value. COPD=chronic obstructive pulmonary disease.
Table 3: Risk factors for COPD
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Discussion
FRESH AIR Uganda was one of the ﬁ rst population-
based, randomised, cross-sectional surveys done in a rural 
area of a sub-Saharan country focused on the prevalence 
and burden of COPD, an unknown disease in the 
community (panel). The prevalence of spirometry-deﬁ ned 
COPD in people older than 30 years was 16%; 39% of 
them, both men and women, were aged 30–39 years.
Where present, airﬂ ow obstruction was not generally 
severe; the same applied to symptoms, health-related 
quality of life, and dyspnoea score. The relevance of 
asymptomatic airﬂ ow obstruction in this population is 
not yet known. However, a ﬁ fth of participants with 
airﬂ ow obstruction had two or more exacerbations in the 
past 12 months.
Almost everybody was exposed to biomass smoke, 
mainly caused by wood ﬁ res in poorly ventilated indoor 
cooking areas.11 Cigarette smoking was prominent in 
young men. Young women hardly smoked at all.11 In 
villages situated among tobacco-growing ﬁ elds, the leaves 
were often dried indoors using an open ﬁ re and guarded 
by elderly people and young children.11 Most people—both 
children and adults—were also exposed to the pollutants 
Figure 3: Smoking status by age and sex for participants with chronic 
obstructive pulmonary disease
Chronic obstructive pulmonary disease deﬁ ned as ratio of forced expiratory 
volume in 1 s to forced vital capacity less than the lower limit of normal.
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Systematic review
In 2011, a systematic review was done of the prevalence and 
eﬀ ect of asthma and chronic obstructive pulmonary disease 
(COPD) in sub-Saharan Africa.10 119 reports were identiﬁ ed: 
32 of asthma, 18 of COPD, 59 of indoor air pollution, and ten of 
primary care, with some overlap. The limited data showed that 
the burden of asthma and COPD was rising.2,10 These diseases 
had not been thought of as major health problems. Tobacco 
smoking was an important risk factor for COPD worldwide, but 
exposure to biomass fuel could be even greater in sub-Saharan 
Africa.9,10 In 2012, a qualitative survey was done in a rural district 
of Uganda to explore beliefs and attitudes about respiratory 
symptoms, use of biomass fuel, tobacco smoking, and use of 
health services.11 The lack of knowledge (the word “COPD” was 
totally unknown) created diﬀ erent beliefs and attitudes about 
respiratory symptoms. Most people used biomass fuels to cook 
and were unaware of the damage to respiratory health caused 
by tobacco and biomass smoke.
Interpretation
In our study, the prevalence of spirometry-deﬁ ned COPD in 
people older than age 30 years was 16·2%. The prevalence 
was especially high (39%) in people aged 30–39 years. Whole 
families are exposed to biomass smoke, mainly caused by 
wood ﬁ res in poorly ventilated cooking areas, starting at early 
age (even in utero). The high prevalence of COPD, especially 
in young people, suggests a hidden health problem and the 
potential for major consequences in the future. Our ﬁ ndings 
suggest that a major priority should be prevention of 
exposure by promotion of awareness of the harmful eﬀ ects of 
biomass fuel use and tobacco smoke in all communities, and 
among health-care workers and policy makers. 
Environmental toxins caused by biomass fuel, tobacco 
smoke, kerosene lamps, and occupational exposure should be 
controlled.5 Simple ventilation, including energy-saving 
stoves and retained-heat cookers, can greatly reduce air 
pollution. Education is needed for behavioural changes.5 
Public health and clinical researchers should work together to 
improve knowledge of early detection, diagnosis, and 
treatment of COPD and to reduce the present and future 
burden of chronic lung disease on health systems. These 
interventions will beneﬁ t people at risk of all 
smoke-attributable morbidity and mortality, not just COPD. 
Odds ratio (95% CI) p value
Smoking
Never smoker 1 (reference) ··
Current smoker 1·669 (0·956–2·914) 0·072
Former smoker 1·960 (1·070–3·589) 0·029
Wheeze
No 1 (reference) ··
Yes 2·174 (1·088–4·344) 0·028
Cough
No 1 (reference) ··
Yes 1·625 (0·956–2·761) 0·073
Heart failure
No 1 (reference) ··
Yes 2·516 (0·979–6·463) 0·055
Time cooking indoors* 1·089 (0·999–1·187) 0·053
See appendix for all results of multivariable analyses. *Hours per day exposed to 
biomass smoke caused by cooking indoors.
Table 4: Selected results of multivariable analyses for chronic obstructive 
pulmonary disease
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from kerosene-based lighting, an under-rated risk factor 
for lung damage.27,28 We detected a strong correlation 
between age and the amount of biomass smoke exposure. 
However, we could not detect a diﬀ erence in COPD 
prevalence in relation to biomass exposure because 
exposure was so common that we lacked a suﬃ  cient 
number of unexposed people to act as a control group. By 
contrast with results from other large prevalence surveys, 
often done in urban areas with participants older than 
40 years,3,6,29 age and sex were not signiﬁ cantly associated 
with COPD in our survey. A major contributor to these 
results could be the low average life expectancy in Uganda.
Our study has several limitations. Spirometry was not 
always done in an ideal environment; nevertheless, the 
results were evaluated in accordance with American 
Thoracic Society and European Respiratory Society 
criteria.6 Appropriate spirometry reference values from 
east Africans did not exist at the time of the survey. We 
used African and south Indian reference values from 
1993.30 In Uganda, as in many countries in Africa, until at 
least a decade ago, registration births was often 
incomplete. People often knew their year of birth, but did 
not know their exact birth date (29% of participants 
reported being born on Jan 1). The diagnosis of COPD 
could be diﬃ  cult in sub-Saharan Africa, where the 
prevalence of comorbid respiratory infections, such as 
tuberculosis, is high. However, the prevalence of 
tuberculosis was low in our study site so we could not 
detect no association with COPD. Likewise, we could not 
test for an association between HIV infection and COPD. 
In rural areas the prevalence of asthma is low compared 
with urban areas.10,31–33 Eight patients with COPD had a 
change in FEV1 of more than 12% and 200 mL after 
a bronchodilator; none of them were known to 
have asthma.
By contrast with the FEV1 and FVC, which are aﬀ ected 
by race and ethnic origin, the FEV1:FVC ratio is generally 
independent of ethnic group and therefore does not 
require speciﬁ c reference values.23,34 Using GLI2012 
DataConversion software, we could deﬁ ne the lower limit 
of normal for the FEV1:FVC ratio with reasonable 
conﬁ dence without reference values for FEV1 and FVC.35 
The lower limit of normal as a criterion made possible 
the identiﬁ cation younger people with an airﬂ ow 
obstruction.
Biomass smoke causes low birthweight and poor lung 
growth, inducing respiratory infections in early childhood 
and causing large and lasting eﬀ ects into adulthood, 
leading to decline of lung function, and substantially 
increasing the risk of COPD.6–9 Tobacco smoke combined 
with exposure to smoke from biomass fuel might even 
have an additive eﬀ ect on the risk of COPD.6,9
Further research is needed to understand the short-
term and long-term eﬀ ects of these risk factors, and their 
association in the early development of COPD. 
Particularly, the progression of airﬂ ow obstruction over 
time needs to be better understood to discover what stage 
in life exposure causes most pulmonary damage. A new 
approach to prevention of lung disease is needed to 
combine education and support, to reduce exposures, 
and recognise and diagnose lung diseases at an early 
stage to minimise their eﬀ ect. Further research is also 
needed into aﬀ ordable and eﬀ ective interventions for 
COPD. COPD could be a major health threat to men and 
women in rural areas of Uganda.
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